Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025303
Filing Date
2021-05-07
Accepted
2021-05-07 07:16:31
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srra-10q_20210331.htm 10-Q 1983431
2 EX-31.1 srra-ex311_6.htm EX-31.1 10029
3 EX-31.2 srra-ex312_7.htm EX-31.2 10032
4 EX-32.1 srra-ex321_8.htm EX-32.1 7470
5 EX-32.2 srra-ex322_9.htm EX-32.2 7417
  Complete submission text file 0001564590-21-025303.txt   6004332

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srra-20210331.xml EX-101.INS 1128270
7 XBRL TAXONOMY EXTENSION SCHEMA srra-20210331.xsd EX-101.SCH 46431
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20210331_cal.xml EX-101.CAL 40305
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20210331_def.xml EX-101.DEF 147170
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20210331_lab.xml EX-101.LAB 369469
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20210331_pre.xml EX-101.PRE 264979
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 21900228
SIC: 2834 Pharmaceutical Preparations